Skip to main content
NewslettersWatchlist

Elanco Animal Health Inc(ELAN-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low16.85
Day High17.42
Open:17.00
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
the globe and mail
the globe and mail

The Globe’s stars and dogs for the week

A humorous look at the companies that caught our eye, for better or worse, this week
Motley Fool
Elanco Animal Health (ELAN) Q1 2024 Earnings Call Transcript
Motley Fool
Elanco Animal Health (ELAN) Q4 2023 Earnings Call Transcript
Barchart
Markets Today: Stocks Slip on Hawkish Fed Comments
Barchart
Chart of the Day: Elanco Animal Health- Big Money in Animal Pharma
Motley Fool
Why Elanco Animal Health Stock Was Pure Catnip to Investors This Week
Motley Fool
Elanco Animal Health (ELAN) Q3 2023 Earnings Call Transcript
Motley Fool
Elanco Animal Health (ELAN) Q2 2023 Earnings Call Transcript
Barchart
Markets Today: Stocks Push Higher on Earnings Optimism
Motley Fool
Why Investors Were Barking Loudly About Elanco Animal Health Stock Today
MarketBeat
Bullish or Bearish? Vetting Animal Health Care Stocks
The Globe and Mail
Expanding array of services for pets offers investors chance to get in on sector’s growth
MarketBeat
Zoetis Declares New Dividend, Hinting At Undervaluation
Motley Fool
2 Unstoppable Growth Stocks Wall Street Thinks Can Soar by at Least 70%
Motley Fool
Elanco Animal Health (ELAN) Q1 2023 Earnings Call Transcript
Business Wire
Elanco Announces Breakthrough Treatment for Deadly Canine Parvovirus
PR Newswire
California Dairies, Inc. and DSM Venturing Complete Strategic Investment in Athian
Business Wire
Elanco Confirms Date and Conference Call for First Quarter 2023 Financial Results Announcement
Business Wire
Elanco to Participate in the Barclays Global Healthcare Conference
Business Wire
Elanco to Participate in the Cowen 43rd Annual Health Care Conference
Business Wire
Elanco to Participate in the Bank of America 2023 Animal Health Summit
Motley Fool
Elanco Animal Health (ELAN) Q4 2022 Earnings Call Transcript
Business Wire
Elanco Animal Health Reports Fourth Quarter and Full Year 2022 Results
Business Wire
Elanco Adds Animal Health Veteran to Executive Committee
MarketBeat
Zoetis, Pet-Med Specialist, Double-Digit Earnings Growth Ahead
Business Wire
Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2022 Financial Results Announcement
Business Wire
Elanco to Participate in the 41st Annual J.P. Morgan Healthcare Conference
Business Wire
Elanco Announces FDA Approval of Bexacat™ (bexagliflozin tablets) – the First-of-its-Kind Oral Feline Diabetes Treatment Option
Business Wire
Elanco to Participate in Evercore ISI 5th Annual HealthCONx Conference
Motley Fool
Elanco Animal Health Inc. (ELAN) Q3 2022 Earnings Call Transcript
Business Wire
Elanco Animal Health Reports Third Quarter 2022 Results
Business Wire
TCW Special Purpose Acquisition Corp. Appoints Nanxi Liu to Board of Directors
Business Wire
Elanco Confirms Date and Conference Call for Third Quarter 2022 Financial Results Announcement

Profile

Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.